Ligand validation:6ZO9

DDR: (2S)-3-hydroxypropane-1,2-diyl didecanoate

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZO9_DDR_B_1102	11%	93%	0.306	0.828	0.23	0.25	-	-	0	0	100%	1
6Q4P_DDR_B_1107	22%	39%	0.284	0.901	1.25	1.14	2	2	0	0	100%	1
6ZO6_DDR_B_1104	18%	40%	0.24	0.83	1.24	1.09	2	2	0	0	100%	1
6ZO8_DDR_B_1105	16%	37%	0.237	0.811	1.24	1.25	2	2	0	0	100%	1
6Q4O_DDR_B_1121	11%	37%	0.345	0.862	1.24	1.25	2	2	0	0	100%	1
6ZO5_DDR_B_1101	9%	38%	0.312	0.8	1.25	1.19	2	2	0	0	100%	1
2Z9Y_DDR_A_1	59%	44%	0.129	0.909	1.18	1	2	2	0	0	100%	1
2Z9Z_DDR_A_1	21%	33%	0.166	0.77	1.24	1.43	2	5	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.